Segle Biotech Skincare — Seed

Early equity financing of the Segle Clinical brand (legal entity Cosmeceuticals Concept SL) with Spanish investor club Faraday Venture Partners entering the cap table; the amount was never disclosed and no lead was stated. Only the year is documented (CB Insights records an unattributed VC round dated to 2021, hence the YYYY-01 convention here), and company directory profiles state that founders Monica Lizondo and Alfonso Fuertes, who bought the SEGLE CLINICAL brand in 2017, have since put more than €500K into the company across two financing rounds, with CB Insights putting total funding at about $1.3M and PitchBook at about $2.39M. Excluded from this list because they are not announced venture rounds: financing from the public Catalan institution Institut Catala de Finances (recorded as a grant/public facility in October 2021), the company's passage through the Lanzadera accelerator, and the €1.5M the company said in August 2026 it is investing to expand its Mexican operation (an internal expansion budget, not a raise).